Reply to the Letter to the Editor: Why Did the "Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists" Differ From the Previous Randomized Controlled Study?
1 Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
2 Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio; The Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio.
3 Hospital for Special Surgery, New York, New York.
4 Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California.
5 Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.